Current Status of Biosimilars and Their Impact on Pharmacovigilance

As the market for biosimilars expands, a nuanced approach is needed to balance cost considerations with patient safety and pharmacovigilance efforts.

Source link
#Current #Status #Biosimilars #Impact #Pharmacovigilance